Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

SLx-2119: a potent ROCK-2 inhibitor that inhibits septic liver injury in vivo

June 25, 2007

Positive topline findings for balsalazide tablets

June 20, 2007

Axcan initiates phase III trial of MAX-002 for ulcerative proctitis

June 18, 2007

ViroPharma makes progress in phase II clinical program for HCV-796

June 18, 2007

Valopicitabine triple combination therapy shows good HCV RNA clearance rates

June 15, 2007

Rolling NDA commences for Zentase

June 14, 2007

Altus reacquires rights to ALTU-135 from Dr. Falk Pharma

June 14, 2007

Recent Japan Tobacco patent reports novel therapeutic agents for HCV infection

June 14, 2007

FDA requests additional data on alvimopan for postoperative ileus

June 13, 2007

DDP-733 reduces esophageal reflux

June 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...